期刊文献+

血清半乳甘露聚糖抗原检测在血液病患者侵袭性曲霉菌病诊断中的应用价值 被引量:10

The retrospective study of serum aspergillus galactomannan (GM) antigen assay in invasive asper-gillosis on hematological diseases
原文传递
导出
摘要 目的探讨血清半乳甘露聚糖(GM)抗原检测(GM试验)在血液病患者侵袭性曲霉菌病(IA)诊断中的应用价值。方法选取2008年1月至2011年12月上海瑞金医院住院的连续2次及以上血常规检查中性粒细胞绝对值〈0.5×10^9/L的血液病患者825例,其中伴发热247例。按《血液病/恶性肿瘤患者侵袭性真菌感染的诊断标准与治疗原则(第三次修订)》将患者分为确诊IA组、临床诊断+拟诊IA组及非IA组。采用ELISA法检测患者血清GM抗原浓度,研究GM值介于0.5—1.5的敏感性和特异度。结果GM值单次≥1.0时,其敏感性为66%,特异度为80%;GM值连续2次≥1.0时,其敏感性为73%,特异度为93%。69例患者确诊为IA,感染率为8.36%。结论连续2次血清GM值≥1.0对于抗曲霉菌治疗具有更大参考价值。 Objective To explore the relationship between the optical density index of serum asper- gillus galactomannan (GM) assay and invasive aspergillosis (IA). Methods From Jan 2008 to Dec 2011, 825 hematological diseases patients with neutrophil count 〈 0.5×10^9/L by continuous blood count tests were admitted into our hospital. The optical density index of GM assay was t〉0.5 at least once. Of 825 patients, 247 cases were manifested as fever during hospitalization. The optical density index of GM antigen was detec- ted by enzyme-linked immunosorbent assay, and the sensitivity and specificity of optical density ranged in 0.5 - 1.5. Results In this study, the sensitivity and specificity of GM assay with continuous twice samples ( 73% and 93 % , respectively) were higher than single sample (66% and 80% , respectively) when optical density index ≥1.0. 69 cases were diagnosed as proven IA with the incidence rate of 8.36%. Conclusion The cut-off level for serum GM antigen assay should be decided as optical density index in two continuous samples of ≥1.0.
出处 《中华血液学杂志》 CAS CSCD 北大核心 2013年第6期498-501,共4页 Chinese Journal of Hematology
关键词 曲霉菌病 侵袭性真菌感染 半乳甘露聚糖 酶联免疫吸附测定 诊断 Aspergillosis Invasive fungal infection Galactomannan Enzyme-linked immu- nosorbent assay Diagnosis
  • 相关文献

共引文献1138

同被引文献105

  • 1马军.侵袭性真菌感染的流行病学[J].中华医学杂志,2005,85(21):1443-1444. 被引量:70
  • 2郑昌成,吴竞生,刘欣,杨会志,韩永胜,王兴兵,朱薇波,蔡晓燕.恶性血液病侵袭性真菌感染的临床研究[J].安徽医学,2007,28(5):389-392. 被引量:4
  • 3重症患者侵袭性真菌感染诊断与治疗指南(2007)[J].中华内科杂志,2007,46(11):960-966. 被引量:448
  • 4Denning DW, Kibhler CC, Barnes RA, etal. British society for medical mycology proposed standards of care for patients with in vasive fungal infections[J]. Lancet Infect Dis, 2003, 3 (4) : 230- 240.
  • 5Rees JR,Pinner RW, ttaiieh RA,et al. The epidemielogical fea- tures of invasive mycotic infections in the San Francisco Bay Are-a, 1992-1993 :resuhs of population-based laboratory active surveil- lance[J]. Clin Infect Dis, 1998,27(5) :1138-1147.
  • 6Denning DW, Hope WW. Therapy for fungal diseases:opportuni- ties and priorities[J]. Trends Microbiol,2010,18(5) :195 204.
  • 7Crump J A, Ramadhani HO, Morrissey AB, et al. Invasive bacterial and fungal infections among hospitalized HIV-infected and HIV- uninfected children and infants in northern Tanzania [J]. Trop Med Int Health, 2011,16(7) :830-837.
  • 8Huang L, Crotbers K. HIV-associated opportunistic pneumonias [J]. Respirology, 2009,14(4) :474-485.
  • 9Shen YZ, Qi TK, Ma JX, et al. Invasive fungal infections among inpatients with acquired immune deficiency syndrome at a Chinese university hospital[J]. Mycoses,2007,50(6) :475-480.
  • 10Onishi A, Sugiyama D, Kogata Y, et al. Diagnostic accuracy of ser um 1,3-β-D-glucan for pneumocystis jiroveci pneumonia, invasive candidiasis, and invasive aspergillosis : systematic review and meta analysis[J]. J Clin Microbiol,2012,50(1)..7-15.

引证文献10

二级引证文献65

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部